Letter From The Editor

Each time I sit down with a group of patients to talk about food choices for diabetes the topic of carbohydrates always comes up. I get a lot of groans when I talk about counting carbs and keeping track, but for the past few months I have been focusing on …

There’s been some interesting research on a compound that appears to be a partner peptide for GLP-1. Oxyntomodulin is released in response to a meal and seems to have a significant effect on glucose levels. Our current PharmD candidate, Farhan Guard, from Lake Erie College of Medicine, found out about this …

There has been a shortage of methylprednisolone and prednisone dose packs available in pharmacies lately and this week’s Disaster Averted deals with what happens when patients get their anti-inflammatory steroids in a bottle instead of a pack. If you’re thinking that the problem is hyperglycemia then you need to review …

The National Committee for Quality Assurance (NCQA) recently held a series of webinars to help clinicians in “Achieving and Outperforming Type 2 Diabetes HEDIS Measures.“ There were a lot of elements that needed to fall into place to make that happen and our Pharm D candidate, Daniel Schultz, listened in …

This week we get back to our interview with Dr. Aaron Vinik, Director, EVMS Strelitz Diabetes Research Center. He has been at the forefront in developing new technologies for growing and regenerating beta cells. Our publisher, Steve Freed, had a few questions for him on how he views the use …

Many times our patients get a Glucagon Kit when they start on insulin and since most patients are taught to only use the injection if they are unconscious, they never use it. However, in this week’s Diabetes Disaster Averted, the use of part of a glucagon injection kit was very …

There was a news release that caught my attention this past week. Eli Lilly announced that the Exenatide tQT Study Showed No Prolongation of QT Interval (See this week’s Item #1). Back in March most of us thought that the FDA would approve the once weekly dose, but instead they …

This week in Part 3 of our Case Study, Mr. Walker and his wife return for a follow-up visit as his glucose control has not improved as much as expected. Click here to see if you agree with the drug choice. In our analysis of the GLP-1 survey data, we …

This week I picked up my new glasses and was chatting with the optometrist about how many of his patients have diabetes. Dr. Adler sees a good number of them as his population is a little older and what surprises him is that they often make no connection between diabetes and …

Steve and Andrew came home with tons of new information from the recent ADA 71st Scientific Sessions. We are going to be sharing the information with you for the next couple of weeks as we continue to review and evaluate the articles and studies. There are articles on new classes …